These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 21958207

  • 1. Syngeneic hematopoietic stem cell transplantation enhances the antitumor immunity of intratumoral type I interferon gene transfer for sarcoma.
    Udagawa T, Narumi K, Goto N, Aida K, Suzuki K, Ochiya T, Makimoto A, Yoshida T, Chikaraishi T, Aoki K.
    Hum Gene Ther; 2012 Feb; 23(2):173-86. PubMed ID: 21958207
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic MHC gene transfer enhances an effective antitumor immunity in the early period of autologous hematopoietic stem cell transplantation.
    Kobayashi A, Hara H, Ohashi M, Nishimoto T, Yoshida K, Ohkohchi N, Yoshida T, Aoki K.
    Clin Cancer Res; 2007 Dec 15; 13(24):7469-79. PubMed ID: 18094431
    [Abstract] [Full Text] [Related]

  • 3. In vivo delivery of interferon-α gene enhances tumor immunity and suppresses immunotolerance in reconstituted lymphopenic hosts.
    Narumi K, Udagawa T, Kondoh A, Kobayashi A, Hara H, Ikarashi Y, Ohnami S, Takeshita F, Ochiya T, Okada T, Yamagishi M, Yoshida T, Aoki K.
    Gene Ther; 2012 Jan 15; 19(1):34-48. PubMed ID: 21614029
    [Abstract] [Full Text] [Related]

  • 4. Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation.
    Suzuki K, Aida K, Miyakawa R, Narumi K, Udagawa T, Yoshida T, Ohshima Y, Aoki K.
    Cancer Med; 2013 Oct 15; 2(5):636-45. PubMed ID: 24403229
    [Abstract] [Full Text] [Related]

  • 5. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation.
    Hara H, Kobayashi A, Narumi K, Kondoh A, Yoshida K, Nishimoto T, Ohashi M, Higashihara E, Ohnami S, Yoshida T, Aoki K.
    Cancer Immunol Immunother; 2009 Jul 15; 58(7):1007-21. PubMed ID: 18998126
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
    Ohashi M, Kobayashi A, Hara H, Miura Y, Yoshida K, Kushida M, Ikarashi Y, Mandai M, Kitajima M, Yoshida T, Aoki K.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2208-15. PubMed ID: 16609036
    [Abstract] [Full Text] [Related]

  • 7. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
    Yim JH, Wu SJ, Casey MJ, Norton JA, Doherty GM.
    J Immunol; 1997 Feb 01; 158(3):1284-92. PubMed ID: 9013971
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse.
    Natsume A, Mizuno M, Ryuke Y, Yoshida J.
    Gene Ther; 1999 Sep 01; 6(9):1626-33. PubMed ID: 10490773
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr 01; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 14. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
    Zhang F, Lu W, Dong Z.
    Clin Cancer Res; 2002 Sep 01; 8(9):2942-51. PubMed ID: 12231540
    [Abstract] [Full Text] [Related]

  • 15. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M, Proietti E, Santodonato L, Gabriele L, Peretti M, Plavec I, Meyer F, Kaido T, Gresser I, Belardelli F.
    Cancer Res; 1993 Mar 01; 53(5):1107-12. PubMed ID: 8439955
    [Abstract] [Full Text] [Related]

  • 16. In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid Administration.
    Nocera DA, Roselli E, Araya P, Nuñez NG, Lienenklaus S, Jablonska J, Weiss S, Gatti G, Brinkmann MM, Kröger A, Morón G, Maccioni M.
    J Immunol; 2016 Mar 15; 196(6):2860-9. PubMed ID: 26880763
    [Abstract] [Full Text] [Related]

  • 17. Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer.
    Ohashi M, Yoshida K, Kushida M, Miura Y, Ohnami S, Ikarashi Y, Kitade Y, Yoshida T, Aoki K.
    Br J Cancer; 2005 Aug 22; 93(4):441-9. PubMed ID: 16106250
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.
    Tada H, Maron DJ, Choi EA, Barsoum J, Lei H, Xie Q, Liu W, Ellis L, Moscioni AD, Tazelaar J, Fawell S, Qin X, Propert KJ, Davis A, Fraker DL, Wilson JM, Spitz FR.
    J Clin Invest; 2001 Jul 22; 108(1):83-95. PubMed ID: 11435460
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.